Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000227083 | SCV000290754 | benign | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258862 | SCV002530548 | benign | Hereditary cancer-predisposing syndrome | 2021-05-18 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002479928 | SCV002798949 | likely benign | Aniridia 1; Drash syndrome; Frasier syndrome; Meacham syndrome; Mesothelioma, malignant; Nephrotic syndrome, type 4; Wilms tumor 1; 11p partial monosomy syndrome | 2022-04-27 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998888 | SCV004831524 | benign | Wilms tumor 1 | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547617 | SCV004735385 | likely benign | WT1-related disorder | 2020-09-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |